Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”

References

• Pepin S, Nicolas JF, Szymanski H, Leroux-Roels I, Schaum T, Bonten M, Icardi G, Shrestha A, Tabar C. QHD00011 study team. Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial. Hum Vaccines Immunother. 2021 ;17(12):1–3. Epub 2021 Oct 29. PMID: 34714720; PMCID: PMC8903946. doi:10.1080/21645515.2021.1983387.
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014 ;371(7):635–645. PMID: 25119609. doi:10.1056/NEJMoa1315727.
   PubMed Web of Science ®Google Scholar
• Van Tilbeurgh M, Lemdani K, Beignon AS, Chapon C, Tchitchek N, Cheraitia L, Marcos Lopez E, Pascal Q, Le Grand R, Maisonnasse P, et al. Predictive markers of immunogenicity and efficacy for human vaccines. Vaccines (Basel). 2021 ;9(6):579. PMID: 34205932; PMCID: PMC8226531. doi:10.3390/vaccines9060579.
   PubMed Web of Science ®Google Scholar
• Olliaro P, Torreele E, Vaillant M. COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room. Lancet Microbe. 2021 ;2(7):e279–e280. Epub 2021 Apr 20. PMID: 33899038; PMCID: PMC8057721. doi:10.1016/S2666-5247(21)00069-0.
   PubMedGoogle Scholar
• Ranganathan P, Pramesh CS, Aggarwal R. Common pitfalls in statistical analysis: absolute risk reduction, relative risk reduction, and number needed to treat. Perspect Clin Res. 2016 ;7(1):51–53. PMID: 26952180; PMCID: PMC4763519. doi:10.4103/2229-3485.173773.
   PubMedGoogle Scholar
• Hashim A, Dang V, Bolotin S, Crowcroft NS. How and why researchers use the number needed to vaccinate to inform decision making–a systematic review. Vaccine. 2015 ;33(6):753–758. doi:10.1016/j.vaccine.2014.12.033.
   PubMed Web of Science ®Google Scholar
• Somes MP, Turner RM, Dwyer LJ, Newall AT. Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: a systematic review and meta-analysis. Vaccine. 2018 ;36(23):3199–3207. Epub 2018 Apr 30. PMID: 29716771. doi:10.1016/j.vaccine.2018.04.063.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Seasonal influenza; 2022. [accessed 2022 Apr 21]. Seasonal influenza (europa.eu)
   Google Scholar
• World Health Organization. Giving influenza vaccination a boost among older people; 2022. [accessed 2022 Apr 21]. WHO/Europe | Giving influenza vaccination a boost among older people.
   Google Scholar
• European Centre for Disease Prevention and Control. Seasonal influenza vaccination and antiviral use in EU/EEA Member States – Overview of vaccine recommendations for 2017–2018 and vaccination coverage rates for 2015–2016 and 2016–2017 influenza seasons; 2018 [accessed 2022 May 10]. Seasonal influenza vaccination and antiviral use in EU/EEA Member States europa.eu
   Google Scholar
• Epidemiologisches Bulletin. Robert Koch institute. Epidemiologisches Bulletin 32/33 2020 (rki.De); 2020. [accessed 2022 Apr 19]. Epidemiologisches Bulletin 32/33 2020 (rki.de)
   Google Scholar
• Advice on influenza vaccines for 2022/23. Joint committee on vaccination and immunisation; 2021 [accessed 2022 Apr 19]. JCVI Statement on Influenza Vaccines 2022-23. pdfnitag-resource.org
   Google Scholar
• Pasté M, Stoffel M, Bardone C, Baron-Papillon F, Czwarno A, Galbraith H, Gastineau T, Germay O, Gonzo D, Juvin P, et al. Addressing vaccine supply challenges in Europe: expert industry perspective and recommendations. Health Policy (New York). 2022 ;126(1):35–42. Epub 2021 Nov 28. doi:10.1016/j.healthpol.2021.11.006.
   Web of Science ®Google Scholar
• Sandmann FG, van Leeuwen E, Bernard-Stoecklin S, Casado I, Castilla J, Domegan L, Gherasim A, Hooiveld M, Kislaya I, Larrauri A, et al. Health and economic impact of seasonal influenza mass vaccination strategies in European settings: a mathematical modelling and cost-effectiveness analysis. Vaccine. 2022 ;40(9):1306–1315. Epub 2022 Jan 31. PMID: 35109968; PMCID: PMC8861572. doi:10.1016/j.vaccine.2022.01.015.
   PubMed Web of Science ®Google Scholar
• Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001 ;344(12):889–896. PMID: 11259722. doi:10.1056/NEJM200103223441204.
   PubMed Web of Science ®Google Scholar
• Cohen SA, Chui KK, Naumova EN. Influenza vaccination in young children reduces influenza-associated hospitalizations in older adults, 2002-2006. J Am Geriatr Soc. 2011 ;59(2):327–332. Epub 2011 Jan 28. PMID: 21275932; PMCID: PMC3111961. doi:10.1111/j.1532-5415.2010.03271.x.
   PubMed Web of Science ®Google Scholar
• Swets MC, Russell CD, Harrison EM, Docherty AB, Lone N, Girvan M, Hardwick HE, Visser LG, Openshaw PJM, Groeneveld GH, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022 ;399(10334):1463–1464. Epub 2022 Mar 25. PMID: 35344735; PMCID: PMC8956294. doi:10.1016/S0140-6736(22)00383-X.
   PubMed Web of Science ®Google Scholar
• Early influenza cases indicate the possibility of severe upcoming season for elderly. European Centre for Disease Prevention and Control; 2021 [accessed 2022 April 19]. Early influenza cases indicate the possibility of severe upcoming season for the elderly (europa.eu).
   Google Scholar
• López Montesinos I, Arrieta-Aldea I, Dicastillo A, Zuccarino F, Sorli L, Guerri-Fernández R, Arnau-Barrés I, Milagro Montero M, Siverio-Parès A, Durán X, et al. Comparison of hospitalized COVID-19 and influenza patients requiring supplemental oxygen in a cohort study: clinical impact and resource consumption. Clin Infect Dis; 2022 :ciac314. Epub ahead of print. PMID: 35442442. doi:10.1093/cid/ciac314.
   PubMed Web of Science ®Google Scholar
• Ashraf M, Rajaram S, English PM. How the COVID 19 pandemic will shape influenza public health initiatives: the UK experience. Hum Vaccin Immunother. 2022 ;18:1–8. Epub ahead of print. PMID: 35435806. doi:10.1080/21645515.2022.2056399.
   Web of Science ®Google Scholar
• Su W, Wang H, Sun C, Li N, Guo X, Song Q, Liang Q, Liang M, Ding X, Sun Y. The association between previous influenza vaccination and COVID-19 Infection risk and severity: a systematic review and meta-analysis. Am J Prev Med. 2022 ;S0749-3797(22):00131–3. Epub ahead of print. PMID: 35410774; PMCID: PMC8920881. doi:10.1016/j.amepre.2022.02.008.
   Google Scholar